Literature DB >> 28176242

Roles of FoxM1 in cell regulation and breast cancer targeting therapy.

Xin Song1, Samuel Selorm Fiati Kenston1, Jinshun Zhao1, Danting Yang2, Yuanliang Gu3.   

Abstract

Forkhead box M1 (FoxM1) is an oncogenic transcription factor involved in a wide variety of cellular processes, such as cell cycle progression, proliferation, differentiation, migration, metabolism and DNA damage response. It is overexpressed in many human cancers, especially in breast cancers. Posttranslational modifications are known to play an important role in regulating the expression and transcriptional activity of FoxM1. In this review, we characterize the posttranslational modifications of FoxM1, summarize modifications of FoxM1 by different kinases, explore the relationship between the different sites of modifications and comprehensively describe how posttranslational modifications to regulate the function of FoxM1 by changing protein stability, nucleus localization and transcriptional activity. Additionally, we systematically summarize the roles of FoxM1 in breast cancer occurrence, therapy and drug resistance. The purpose of this paper tries to give a better understanding of the regulatory mechanisms of FoxM1 in cell regulation and highlights potential of a new method for breast cancer therapy by targeting FoxM1.

Entities:  

Keywords:  Breast cancer; Cell regulation; FoxM1; Targeting therapy

Mesh:

Substances:

Year:  2017        PMID: 28176242     DOI: 10.1007/s12032-017-0888-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  91 in total

1.  FoxM1 is required for execution of the mitotic programme and chromosome stability.

Authors:  Jamila Laoukili; Matthijs R H Kooistra; Alexandra Brás; Jos Kauw; Ron M Kerkhoven; Ashby Morrison; Hans Clevers; René H Medema
Journal:  Nat Cell Biol       Date:  2005-01-16       Impact factor: 28.824

2.  FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  FEBS J       Date:  2006-09-11       Impact factor: 5.542

Review 3.  FOXM1, a typical proliferation-associated transcription factor.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2007-12       Impact factor: 3.915

4.  The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site.

Authors:  Inken Wierstra; Jürgen Alves
Journal:  Biol Chem       Date:  2007-08       Impact factor: 3.915

5.  The Forkhead box M1 protein regulates the transcription of the estrogen receptor alpha in breast cancer cells.

Authors:  Patricia A Madureira; Rana Varshochi; Demetra Constantinidou; Richard E Francis; R Charles Coombes; Kwok-Ming Yao; Eric W-F Lam
Journal:  J Biol Chem       Date:  2006-06-28       Impact factor: 5.157

6.  Over-expression of FoxM1 stimulates cyclin B1 expression.

Authors:  T W Leung; S S Lin; A C Tsang; C S Tong; J C Ching; W Y Leung; R Gimlich; G G Wong; K M Yao
Journal:  FEBS Lett       Date:  2001-10-19       Impact factor: 4.124

7.  Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.

Authors:  Vladimir V Kalinichenko; Michael L Major; Xinhe Wang; Vladimir Petrovic; Joseph Kuechle; Helena M Yoder; Margaret B Dennewitz; Brian Shin; Abhishek Datta; Pradip Raychaudhuri; Robert H Costa
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

8.  Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

Authors:  Jörg van den Boom; Marietta Wolter; Rork Kuick; David E Misek; Andrew S Youkilis; Daniel S Wechsler; Clemens Sommer; Guido Reifenberger; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.

Authors:  Il-Man Kim; Timothy Ackerson; Sneha Ramakrishna; Maria Tretiakova; I-Ching Wang; Tanya V Kalin; Michael L Major; Galina A Gusarova; Helena M Yoder; Robert H Costa; Vladimir V Kalinichenko
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

10.  The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.

Authors:  Yanan Zhang; Jie Liu; Shibin Wang; Xiaoli Luo; Yang Li; Zhaohui Lv; Jie Zhu; Jing Lin; Lihua Ding; Qinong Ye
Journal:  Oncotarget       Date:  2016-04-26
View more
  17 in total

1.  FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells.

Authors:  Zuhal Hamurcu; Nesrin Delibaşı; Ufuk Nalbantoglu; Elif Funda Sener; Nursultan Nurdinov; Bayram Tascı; Serpil Taheri; Yusuf Özkul; Hamiyet Donmez-Altuntas; Halit Canatan; Bulent Ozpolat
Journal:  J Mol Med (Berl)       Date:  2019-02-07       Impact factor: 4.599

2.  USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1.

Authors:  Zhenwang Zhang; Wu Liu; Xiajun Bao; Tian Sun; Jiawei Wang; Mengxi Li; Chao Liu
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

Review 3.  PROTACs: great opportunities for academia and industry (an update from 2020 to 2021).

Authors:  Ming He; Chaoguo Cao; Zhihao Ni; Yongbo Liu; Peilu Song; Shuang Hao; Yuna He; Xiuyun Sun; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2022-06-09

4.  TRIM56 Reduces Radiosensitization of Human Glioblastoma by Regulating FOXM1-Mediated DNA Repair.

Authors:  Yun Dong; Yiping Xiong; Duanyang Zhou; Min Yao; Xiao Wang; Wenchuan Bi; Jian Zhang
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

5.  RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.

Authors:  Amy C Mandigo; Wei Yuan; Kexin Xu; Peter Gallagher; Angel Pang; Yi Fang Guan; Ayesha A Shafi; Chellappagounder Thangavel; Beshara Sheehan; Denisa Bogdan; Alec Paschalis; Jennifer J McCann; Talya S Laufer; Nicolas Gordon; Irina A Vasilevskaya; Emanuela Dylgjeri; Saswati N Chand; Matthew J Schiewer; Josep Domingo-Domenech; Robert B Den; Jeff Holst; Peter A McCue; Johann S de Bono; Christopher McNair; Karen E Knudsen
Journal:  Cancer Discov       Date:  2021-04-20       Impact factor: 39.397

6.  Identification of Biomarkers Correlated with the TNM Staging and Overall Survival of Patients with Bladder Cancer.

Authors:  Sheng Li; Xiaoping Liu; Tongzu Liu; Xiangyu Meng; Xiaohong Yin; Cheng Fang; Di Huang; Yue Cao; Hong Weng; Xiantao Zeng; Xinghuan Wang
Journal:  Front Physiol       Date:  2017-11-28       Impact factor: 4.566

Review 7.  Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review.

Authors:  Siti Muhamad Nur Husna; Hern-Tze Tina Tan; Rohimah Mohamud; Anne Dyhl-Polk; Kah Keng Wong
Journal:  Ther Adv Med Oncol       Date:  2018-11-09       Impact factor: 8.168

8.  MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1.

Authors:  Shuguang Cao; Limiao Lin; Xuanping Xia; Hao Wu
Journal:  Oncotarget       Date:  2017-08-10

9.  REINDEER: efficient indexing of k-mer presence and abundance in sequencing datasets.

Authors:  Camille Marchet; Zamin Iqbal; Daniel Gautheret; Mikaël Salson; Rayan Chikhi
Journal:  Bioinformatics       Date:  2020-07-01       Impact factor: 6.937

10.  Identification of FOXM1 as a specific marker for triple‑negative breast cancer.

Authors:  Yanli Tan; Qixue Wang; Yingbin Xie; Xiaoxia Qiao; Shun Zhang; Yanan Wang; Yongbin Yang; Bo Zhang
Journal:  Int J Oncol       Date:  2018-10-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.